DETERMINE news hub

Discover the latest updates on the DETERMINE trial including updates on our progress, site openings, and partnership initiatives. 

Learn more about DETERMINE

2023

• Citeline: The Script Award categories 2023 
• The Guardian: Patients with rare cancers given hope by UK-led ‘drug-match’ trial 
• PRIME-ROSE: Official Opening of the Horizon EU Cancer Mission PRIME-ROSE project
• The Herald: Scotland cancer: First-of-its-kind trial to test new treatment 
• The Independent: Scots with rare cancers to test new treatment in first-of-its-kind trial 
• The Times: Scotland cancer patients will be first to try precision treatment
• The Standard: Scots with rare cancers to test new treatment in first-of-its-kind trial
• The National: Scots with rare cancers to test new treatment in first-of-its-kind trial 
• Accelerate: Fair for AYA stamp 
• Cancer Research Horizons: The DETERMINE trial: showcasing Cancer Research UK’s unique position in the pharma industry
• Cancer Research Horizons: Cancer Research UK joins European precision cancer medicine trial consortium 

2022

• Cancer Research Horizons: Novartis joins Cancer Research UK trial for rare cancers
• Cancer Research Horizons: Precision medicine trial opens for rare adult and paediatric cancers 
• Bionow: A fabulous night of accolades at the 2022 Bionow Awards Dinner 
• Bionow: Introducing the 2022 Bionow Awards Shortlist!